PRESS RELEASES Clear Filters March 12, 2026 Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update Read More February 19, 2026 Gain Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference Read More January 7, 2026 Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week Read More January 6, 2026 Gain Therapeutics Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 Read More December 18, 2025 Gain Therapeutics to Host Virtual KOL Event on GT-02287 for Parkinson’s Disease Read More December 18, 2025 Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease Read More View More IN THE NEWS Clear Filters February 18, 2026 Gain Therapeutics Shares Promising Phase 1 Data on GT-02287 https://investorshangout.com/gain-therapeutics-shares-promising-phase-1-data-on-gt02287-46943-/ Read More January 26, 2026 5 Investigational Therapies That Could Change the Parkinson’s Landscape https://www.biospace.com/drug-development/5-investigational-therapies-that-could-change-the-parkinsons-landscape Read More January 13, 2026 Early trial data suggest GT-02287 may aid Parkinson’s symptoms https://parkinsonsnewstoday.com/news/early-trial-data-suggest-gt-02287-aid-parkinsons-symptoms/ Read More January 9, 2026 New data suggest enzyme modulator may slow Parkinson’s https://longevity.technology/news/new-data-suggest-enzyme-modulator-may-slow-parkinsons/ Read More January 7, 2026 Empowered Patient Podcast: Reality Check from Biotech Leaders on Using AI in Drug Discovery with BioXcel Therapeutics Gain Therapeutics iBio https://empoweredpatientradio.com/reality-check-from-biotech-leaders-on-using-ai-in-drug-discovery-with-bioxcel-therapeutics-gain-therapeutics-ibio Read More December 18, 2025 Early signals stack up: Two small molecules activate GCase in Parkinson’s https://www.biocentury.com/article/657912/early-signals-stack-up-two-small-molecules-activate-gcase-in-parkinson-s Read More View More EVENTS Clear Filters February 25, 2026 Oppenheimer Fireside Chat with President and CEO Gene Mack – 36th Annual Healthcare Life Sciences Conference Read More January 6, 2026 Parkinson’s Disease KOL Event: Understanding GCase Substrates in Parkinson’s Disease – Perspectives on Biomarkers and Disease Modification Read More October 13, 2025 Parkinson’s Disease KOL Event: Biomarkers, Clinical Endpoints, and the Path to Disease Modification Read More May 21, 2025 Citizens Life Sciences Conference Company Presentation Read More March 17, 2025 ROTH Fireside Chat with President & CEO Gene Mack Read More August 8, 2024 BTIG Fireside Chat with Interim CEO Gene Mack and CMO Jonas Hannestad – Virtual Biotechnology Conference 2024 Read More View More
